NCT01037088View on ClinicalTrials.gov

Effects of Vaporized Marijuana on Neuropathic Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Neuropathic PainReflex Sympathetic DystrophyPeripheral NeuropathyPost-herpetic NeuralgiaSpinal Cord InjuryMultiple Sclerosis
Interventions
DRUG

Mild dose cannabis

3.53% THC by weight

DRUG

Low dose cannabis

1.29% THC by weight

DRUG

Cannabis

0.00% THC by weight

Trial Locations (1)

95817

CTSC Clinical Research Center, Sacramento VA Medical Center, Sacramento

Sponsors
All Listed Sponsors
collaborator

Center for Medicinal Cannabis Research

OTHER

collaborator

VA Northern California Health Care System

FED

lead

University of California, Davis

OTHER